NCT04832776 2021-04-06
FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases
Fudan University
Phase 2 Unknown
Fudan University
Sun Yat-sen University
Oncology Institute of Vojvodina
Rabin Medical Center
International Group of Endovascular Oncology
Odense University Hospital